(Q38314583)

2 September 2017

title

Effects of ARHI on breast cancer cell biological behavior regulated by microRNA-221. (English)

1 reference

2 September 2017

1 reference

Ying Li

1

1 reference

2 September 2017

Mei Liu

2

1 reference

2 September 2017

Yanjun Zhang

3

1 reference

2 September 2017

Chun Han

4

1 reference

2 September 2017

Junhao You

5

1 reference

2 September 2017

Junlan Yang

6

1 reference

2 September 2017

Cheng Cao

7

1 reference

2 September 2017

Shunchang Jiao

8

1 reference

2 September 2017

publication date

26 June 2013

1 reference

2 September 2017

1 reference

2 September 2017

volume

34

1 reference

2 September 2017

issue

6

1 reference

2 September 2017

page(s)

3545-3554

1 reference

Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysis

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

miR-7 and miR-218 epigenetically control tumor suppressor genes RASSF1A and Claudin-6 by targeting HoxB3 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

Identification and pathway analysis of microRNAs with no previous involvement in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

Identification of novel targets for miR-29a using miRNA proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

Inhibition of microRNA-302 (miR-302) by bone morphogenetic protein 4 (BMP4) facilitates the BMP signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

microRNA regulation of cell viability and drug sensitivity in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

Macro-role of microRNA in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

microRNAs in cancer management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

Circulating microRNAs as noninvasive biomarkers in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

miR-221 overexpression contributes to liver tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

Clinical significance of miR-221 and its inverse correlation with p27Kip¹ in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

miR-221 silencing blocks hepatocellular carcinoma and promotes survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

Anti-microRNA-222 (anti-miR-222) and -181B suppress growth of tamoxifen-resistant xenografts in mouse by targeting TIMP3 protein and modulating mitogenic signal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

Quantitative analysis of microRNAs in tissue microarrays by in situ hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

MicroRNAs 221/222 and Genistein-Mediated Regulation of ARHI Tumor Suppressor Gene in Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

Effects of ARHI on cell cycle progression and apoptosis levels of breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

p27(Kip1) V109G polymorphism and cancer risk: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

Aplasia ras homolog member I is downregulated in gastric cancer and silencing its expression promotes cell growth in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

The expression and clinical significance of GTP-binding RAS-like 3 (ARHI) and microRNA 221 and 222 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

Aplasia Ras homologue member I overexpression induces apoptosis through inhibition of survival pathways in human hepatocellular carcinoma cells in culture and in xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

Reactivation of the silenced and imprinted alleles of ARHI is associated with increased histone H3 acetylation and decreased histone H3 lysine 9 methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

The therapeutic potential of microRNAs in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0933-6

Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer.

21 January 2018

1 reference

12 December 2020

Breast cancer manifested by hematologic disorders

1 reference

12 December 2020

Proteomic studies in breast cancer (Review).

1 reference

12 December 2020

miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer

1 reference

12 December 2020

MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship

1 reference

12 December 2020

Brain metastases in HER2 positive breast cancer: the next hurdle.

1 reference

12 December 2020

Persistent pain after breast cancer treatment

1 reference

12 December 2020

Medical oncology in Asia

1 reference

12 December 2020

LOH at 1p31 (ARHI) and proliferation in lymph node-negative breast cancer.

1 reference

12 December 2020

MicroRNAs in esophageal cancer (review).

1 reference

12 December 2020

The evolution of the role of surgery in the management of breast cancer lung metastasis.

1 reference

12 December 2020

Marine fungal metabolite 1386A alters the microRNA profile in MCF-7 breast cancer cells

1 reference

12 December 2020

ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers

1 reference

12 December 2020

Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.

1 reference

12 December 2020

10.1007/S13277-013-0933-6

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

1030764155

0 references

1 reference